2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid
C27H26N2O5S2 — CID 122422749
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid
2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid (PubChem CID 122422749) has the molecular formula C27H26N2O5S2 and a molecular weight of 522.65 g/mol. Its IUPAC name is 2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid.
Molecular Properties
| Compound Name | 2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid |
|---|---|
| PubChem CID | 122422749 |
| Molecular Formula | C27H26N2O5S2 |
| Molecular Weight | 522.65 g/mol |
| Exact Mass | 522.13 |
| IUPAC Name | 2-[6-[2-[4-(3-ethoxyphenyl)phenyl]-1-(thiophen-2-ylsulfonylamino)ethyl]-2-pyridinyl]acetic acid |
| SMILES | CCOc1cccc(-c2ccc(CC(NS(=O)(=O)c3cccs3)c3cccc(CC(=O)O)n3)cc2)c1 |
| InChI | InChI=1S/C27H26N2O5S2/c1-2-34-23-8-3-6-21(17-23)20-13-11-19(12-14-20)16-25(29-36(32,33)27-10-5-15-35-27)24-9-4-7-22(28-24)18-26(30)31/h3-15,17,25,29H,2,16,18H2,1H3,(H,30,31) |
| InChIKey | OMANEAYUKUNASD-UHFFFAOYSA-N |
| XLogP | 5.10 |
| TPSA | 105.59 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 522.65 |
| LogP ≤ 5 | 5.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122422749 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.